Compound Detail
CHEMBL5219502
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCC(=O)Nc1ccc(N2CCN(c3ccc(OC[C@@H]4CO[C@@](Cn5cncn5)(c5ccc(Cl)cc5Cl)O4)cc3)CC2)cc1
Basic Information
| ChEMBL ID | CHEMBL5219502 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | QGXQDJRDBZYCGO-AKGWNBJDSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
4
Publications
0
Known Names
Molecular Properties
637.6
MW (Da)
5.61
ALogP
9
HBA
1
HBD
94.0
PSA (Ų)
0.24
QED
2
Ro5 Violations
10
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 6.06
Target Activity Profile
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 873.0 | nM | 6.06 | Inhibition of hedgehog signalling pathway in human A549 cells assessed as reduct... | 36184028 |
| A549 | IC50 | = | 2550.0 | nM | 5.59 | Antiproliferative activity against human A549 cells assessed as inhibition of ce... | 36184028 |
| HepG2 | IC50 | = | 5460.0 | nM | 5.26 | Antiproliferative activity against human HepG2 cells assessed as inhibition of c... | 36184028 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 36184028 | 10.1016/j.bmcl.2022.129011 | Unchecked | 1 |
| 36184028 | 10.1016/j.bmcl.2022.129011 | A549 | 1 |
| 36184028 | 10.1016/j.bmcl.2022.129011 | HepG2 | 1 |
| 36184028 | 10.1016/j.bmcl.2022.129011 | L02 | 1 |
Data from ChEMBL 36 via Core Engine